Literature DB >> 21846642

Pacing-induced cardiomyopathy in patients with right ventricular stimulation for >15 years.

Henryk Dreger1, Katja Maethner, Hansjürgen Bondke, Gert Baumann, Christoph Melzer.   

Abstract

AIMS: The prevalence of pacing-induced cardiomyopathy (PiCMP) has been reported to be 9% 1 year after implantation. As long-term data are sparse, the aim of our study was to evaluate the prevalence of PiCMP in a cohort of patients with at least 15 years of right ventricular (RV) pacing. METHODS AND
RESULTS: Inclusion criteria were RV stimulation for at least 15 years due to atrioventricular block III° and absence of structural heart disease at the time of initial implantation. All patients were examined by echocardiography and spiroergometry. Pacing-induced cardiomyopathy was pre-defined as left ventricular (LV) ejection fraction (LVEF) ≤45%, dyskinesia during RV pacing and absence of other known causes of cardiomyopathy. Twenty-six patients from our outpatient department met the inclusion criteria. Pacing-induced cardiomyopathy was diagnosed in four patients (15.4%). Echocardiography showed significant LV remodelling in PiCMP patients [LVEF 41.0 ± 4.5%, LV end-diastolic diameter (LVEDD) 54.0 ± 2.7 mm] compared with patients with preserved LVEF (LVEF 61.2 ± 5.8%, P = 0.002, LVEDD 45.6 ± 4.0 mm, P= 0.004). There were no significant differences regarding age, gender, duration of RV pacing, heart rate, interventricular mechanical delay, QRS duration or prevalence of sinus rhythm, and arterial hypertension between both groups. The longest intraventricular delay was significantly shorter in patients with preserved LVEF (65.5 ± 43.0 ms) compared with PiCMP patients (112.5 ± 15.0 ms, P= 0.043). Exercise capacity and quality of life did not differ significantly between both groups.
CONCLUSION: Considering the very long duration of RV stimulation in our study population (24.6 ± 6.6 years), the prevalence of PiCMP was remarkably low. Pacing-induced cardiomyopathy was associated with more pronounced intraventricular dyssynchrony.

Entities:  

Mesh:

Year:  2011        PMID: 21846642     DOI: 10.1093/europace/eur258

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  32 in total

1.  Incidence and predictors of pacemaker-induced cardiomyopathy with comparison between apical and non-apical right ventricular pacing sites.

Authors:  Raghav Bansal; Neeraj Parakh; Anunay Gupta; Rajnish Juneja; Nitish Naik; Rakesh Yadav; Gautam Sharma; Ambuj Roy; Sunil Kumar Verma; Vinay Kumar Bahl
Journal:  J Interv Card Electrophysiol       Date:  2019-07-30       Impact factor: 1.900

Review 2.  The role of biventricular pacing in the prevention and therapy of pacemaker-induced cardiomyopathy.

Authors:  Maya Guglin; S Serge Barold
Journal:  Ann Noninvasive Electrocardiol       Date:  2015-01-06       Impact factor: 1.468

3.  Right ventricular pacing is associated with increased rates of appropriate implantable cardioverter defibrillator shocks.

Authors:  Liane A Arcinas; William F McIntyre; Ashraf Farag; Dominique Kushneriuk; Brett Hiebert; Colette M Seifer
Journal:  Ann Noninvasive Electrocardiol       Date:  2019-02-05       Impact factor: 1.468

4.  Antegrade Conduction Rescues Right Ventricular Pacing-Induced Cardiomyopathy in Complete Heart Block.

Authors:  James F Dawkins; Yu-Feng Hu; Jackelyn Valle; Lizbeth Sanchez; Yong Zheng; Eduardo Marbán; Eugenio Cingolani
Journal:  J Am Coll Cardiol       Date:  2019-04-09       Impact factor: 24.094

Review 5.  Pacing-induced cardiomyopathy: pathophysiological insights through matrix metalloproteinases.

Authors:  Fozia Z Ahmed; Rajdeep S Khattar; Amir M Zaidi; Ludwig Neyses; Delvac Oceandy; Mamas Mamas
Journal:  Heart Fail Rev       Date:  2014-09       Impact factor: 4.214

6.  DDD mode-switching and loss of atrioventricular synchrony evokes heart failure: A rare but possible trigger of pacing-induced cardiomyopathy.

Authors:  Daisetsu Aoyama; Moe Mukai; Kenichi Kaseno; Toshihiko Tsuji; Keiichi Sakakibara; Kanae Hasegawa; Minoru Nodera; Shinsuke Miyazaki; Hiroyasu Uzui; Hiroshi Tada
Journal:  J Cardiol Cases       Date:  2020-11-21

7.  Efficacy of optimal medical therapy and cardiac resynchronization therapy upgrade in patients with pacemaker-induced cardiomyopathy.

Authors:  Marius Schwerg; Henryk Dreger; Wolfram C Poller; Benjamin Dust; Christoph Melzer
Journal:  J Interv Card Electrophysiol       Date:  2015-09-24       Impact factor: 1.900

8.  Which Patients with AV Block Should Receive CRT Pacing?

Authors:  Tanyanan Tanawuttiwat; Alan Cheng
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-03

9.  Clinical characteristics associated with pacing-induced cardiac dysfunction: a high incidence of undiagnosed cardiac sarcoidosis before permanent pacemaker implantation.

Authors:  Yasushi Wakabayashi; Takeshi Mitsuhashi; Naoyuki Akashi; Takekuni Hayashi; Tomio Umemoto; Yoshitaka Sugawara; Hideo Fujita; Shin-Ichi Momomura
Journal:  Heart Vessels       Date:  2018-06-21       Impact factor: 2.037

Review 10.  His Bundle Pacing: A New Frontier in the Treatment of Heart Failure.

Authors:  Nadine Ali; Daniel Keene; Ahran Arnold; Matthew Shun-Shin; Zachary I Whinnett; S M Afzal Sohaib
Journal:  Arrhythm Electrophysiol Rev       Date:  2018-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.